Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study

Published:2015-12-23 Issue:4 Volume:21 Page:676-683
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Itokawa Norio,Atsukawa Masanori,Tsubota Akihito,Okubo Tomomi,Arai Taeang,Nakagawa Ai,Kondo Chisa,Iwakiri Katsuhiko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-015-0942-0.pdf

Reference43 articles.

1. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

2. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917

3. European Association For The Study Of The Liver1, European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines management of hepatocellular carcinoma. J Hepatol 56:908–943

4. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390

5. Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia–Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25–34

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of the relationship between autophagy and sorafenib-resistance in hepatocellular carcinoma: ferroptosis is noteworthy;Frontiers in Cell and Developmental Biology;2023-04-27

2. Targeted therapy for hepatocellular carcinoma;Signal Transduction and Targeted Therapy;2020-08-11

3. The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis;Scientific Reports;2017-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3